Stay informed. See MDA updates on COVID-19

Medical Educational Resource

We're accelerating the delivery of treatments and cures.

Duchenne Best Practices For Physical Therapy

Activity Snapshot

Activity Type: 
On-Demand Webinar
Release Date: 
Tuesday, August 4, 2020
Expiration Date: 
Thursday, August 3, 2023

Faculty

Claudia Senesac, PT, PhD, PCS
Claudia Senesac, PT, PhD, PCS
Clinical Professor
University of Florida
Duchenne Best Practices For Physical Therapy
Activity Overview: 

An overview of physical therapy methods and approaches for patents with Duchenne muscular dystrophy, including common signs and symptoms, role of physical therapy, and benefits of exercise and stretching for young and older boys with DMD.

Learning Objectives: 
  • Better prepared to meet the challenges of the rapidly evolving neuromuscular treatment landscape
  • Better able to identify patients who are eligible for new treatments or clinical trials
  • Able to implement principles of the multidisciplinary care approach
Accreditation and Designation Statement: 

The PeerPoint Medical Education Institute, LLC designates this Enduring activity for the number of AMA PRA Category 1 Credits™ listed below. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Duchenne Best Practices For Physical Therapy
1.25 AMA PRA Category 1 Credits™
Release Date: August 4, 2020
Expiration Date: August 3, 2023

How to Obtain CME credits : 

Once you have viewed the program, MDA will share back with you instructions for how to obtain your CME credits. If you have questions on this process, please reach out to cmemanagement@mdausa.org.

Faculty Disclosures: 

The following planners have relevant financial relationships to disclose:

"I, or an immediate family member, have at present or have had within the last 12 months, the following affiliation with one or more organizations that could be perceived as a real or apparent conflict of interest in context to the design, implementation, presentation, evaluation, etc. of CME Activities."

Dr. Ali Habib

Alexion Pharm.: Med Advis Bd, Speaker Bureau; consulting fees
Argenx, Alnylam Pharm.: Medical Advisory Board; consulting fees

Dr. Lisa Wolfe

Hill-Rom, Philips, ResMed: Site PI; Grant Funding

Ms. Tina Duong

Roche: Consulting, advisory board; consulting fees
Scholar Rock, Pfizer, Sanofi Genzyme: advisory board; consulting fees
Audentes: advisory board, consulting; consulting fees
Solid Bio: consulting; consulting fees
Novartis: advisory board and PT training; consulting fee

All other presenters, planners, editors, or staff reported no relevant relationships with the following statement:

"I, or an immediate family member, do not have at present, or within the last 12 months, nor anticipate having financial interest, arrangement or affiliation with any organizations that could be perceived as a real or apparent conflict of interest in context to the design, implementation, presentation, evaluation, etc. of CME Activities."

Copyright 2021 Muscular Dystrophy Association. All rights reserved. The Medical Education Program(s) in their entirety (including, but not limited to: webinar(s), speaker deck presentation(s), MDA Monthly Report content and case studies) are owned by Muscular Dystrophy Association and the associated partner(s) and may not be copied, reproduced, or altered in any manner without MDA’s prior written consent except that the User(s) may download, view, or use these program(s) for educational purposes only.

The Terms of Use permit User(s) to use the Medical Education Program(s) for personal and/or public education only. A User may download the information to share but will not be permitted to alter the information in any way. The User(s) is permitted to educate on one or all sections of the program(s). Any appropriate use of content available from the Medical Education Program(s) must not remove any trademarks, copyright, or any other notice contained in such content.

If you wish to alter any of the Medical Education Program(s) presented by the MDA in a form other than what is set out on mda.org, please consult meded@mdausa.org.